IV Sterile Compounding Risks and Safety
Instructor:
Scarlett Eckert
Product ID: 706464
- Duration: 90 Min
Why Should You Attend:
- Do you know the key risk factors when compounding sterile CSPs?
- Do you know the main source of contaminates entering the cleanroom?
- Do you understand regulatory requirements for safe compounding of sterile CSPs?
- Do you know how to protect yourself and your staff from hazardous drug exposure?
- Do you know how to protect the general public from hazardous drug exposure?
This webinar will explain the proper handling of NIOSH listed drugs from receiving to disposal and all handling processes in between: storage, dispensing, compounding.
Learning Objectives:
- Review the severity of IV compounding errors.
- Review the New ‘proposed’ USP <797> requirements addressing IV compounding safety.
- Review the USP <800> personnel, environment and patient safety requirements.
- Describe the components of IV compounding errors.
- Identify which risk factors and safety issues can be mitigated.
- Discuss how to mitigate risk factors and improve safety of your cleanroom practices and compounded sterile products.
Who Will Benefit:
- Pharmacist, Pharmacy Technician, Physician, Nurse, Health Clinic Staff, Retail Pharmacy Staff, Physician Office Staff
Free Materials:
- Copy of Power Point Slides
Scarlett Eckert
Independent Consultant, Eckert Healthcare Consulting
Dr. Eckert received her Doctor of Pharmacy degree from the University of the Pacific, in Stockton, California. Scarlett is currently working as an independent consultant pharmacist.
She is an expert on pharmacy regulatory requirements including USP Chapter <797> Pharmaceutical Compounding – Sterile Preparations, current and proposed revision and USP <800> Hazardous Drugs – Handling In Healthcare Settings. She has completed certification in Aseptic Process and Compliance Tools for USP <797> and USP <800> Safe Handling and Preparation of Cytotoxic and Other Hazardous Drugs from the Baxa Star Center, Parker, Colorado, and Best Practices for Handling Hazardous Drugs (USP 800) from the Clinical Point Training Center, Totowa, NJ. She participated on the ISMP IV Safety Summit in 2011.
Dr. Eckert specializes in working with individual hospitals, large health systems, specialty compounding centers in understanding and how to implement USP Chapters regulations and develop safe sterile compounding practices in the Unites States and Canada.
Refund Policy
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
